Behind the Scenes of Humana's Latest Options Trends

Comments
Loading...

Financial giants have made a conspicuous bearish move on Humana. Our analysis of options history for Humana HUM revealed 10 unusual trades.

Delving into the details, we found 30% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $113,577, and 7 were calls, valued at $382,185.

Projected Price Targets

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $250.0 and $320.0 for Humana, spanning the last three months.

Volume & Open Interest Development

In today's trading context, the average open interest for options of Humana stands at 397.5, with a total volume reaching 378.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Humana, situated within the strike price corridor from $250.0 to $320.0, throughout the last 30 days.

Humana Option Activity Analysis: Last 30 Days

Options Call Chart

Noteworthy Options Activity:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume
HUM CALL TRADE NEUTRAL 01/15/27 $66.8 $60.2 $64.0 $280.00 $128.0K 82 20
HUM CALL TRADE BEARISH 02/21/25 $31.2 $30.3 $30.6 $250.00 $76.5K 168 25
HUM PUT TRADE BULLISH 02/21/25 $41.9 $39.1 $39.79 $305.00 $51.7K 29 13
HUM CALL SWEEP BEARISH 04/17/25 $10.5 $10.3 $10.3 $320.00 $48.4K 18 55
HUM CALL SWEEP BEARISH 01/17/25 $2.25 $2.1 $2.1 $290.00 $42.0K 562 230

About Humana

Humana is one of the largest private health insurers in the us with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

After a thorough review of the options trading surrounding Humana, we move to examine the company in more detail. This includes an assessment of its current market status and performance.

Present Market Standing of Humana

  • With a volume of 950,088, the price of HUM is up 1.23% at $265.71.
  • RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.
  • Next earnings are expected to be released in 17 days.

What Analysts Are Saying About Humana

A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $295.5.

Unusual Options Activity Detected: Smart Money on the Move

Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access. * Consistent in their evaluation, an analyst from Morgan Stanley keeps a Equal-Weight rating on Humana with a target price of $301. * An analyst from Truist Securities persists with their Hold rating on Humana, maintaining a target price of $290.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for Humana, Benzinga Pro gives you real-time options trades alerts.

Overview Rating:
Speculative
50%
Technicals Analysis
66
0100
Financials Analysis
40
0100
Overview
Market News and Data brought to you by Benzinga APIs
Date of Trade
ticker
Put/Call
Strike Price
DTE
Sentiment

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!